ACH-806
ACH-806 is an NS4A antagonist which can inhibit Hepatitis C Virus (HCV) replication with an EC50 of 14 nM.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 870142-71-5
- Formel: C19H20F3N3O2S
- Molecular Weight:411.44
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
HY-14434
AsunaprevirHCV Protease Inhibitor -
HY-10241
SimeprevirHCV NS3/4A Inhibitor -
HY-15298
GrazoprevirHCV Protease Inhibitor -
HY-10238
DanoprevirHCV NS3/4A Inhibitor -
HY-10237
BoceprevirHCV NS3 Protease Inhibitor -
HY-10300
NarlaprevirNS3 Protease Inhibitor -
HY-10465
Daclatasvir dihydrochlorideHCV NS5A Inhibitor -
HY-15298A
Grazoprevir potassium saltHCV Inhibitor -
HY-10235
TelaprevirHCV NS3-4A Protease Inhibitor -
HY-10465R
Daclatasvir dihydrochloride (Standard)HCV NS5A Inhibitor -
HY-15298B
Grazoprevir hydrateHCV Protease Inhibitor -
HY-15602
LedipasvirHCV NS5A Inhibitor
Biologische Aktivität
Beschreibung
IC50 & Target
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Huh-7 | EC50 |
28.2 nM
Compound: GS-9132, ACH-806
|
Antiviral activity against HCV1b Con1 harboring NS3 protease gene infected in human Huh7/Lunet cells assessed as inhibition of viral replication after 3 days by luciferase based transient-transfection assay
Antiviral activity against HCV1b Con1 harboring NS3 protease gene infected in human Huh7/Lunet cells assessed as inhibition of viral replication after 3 days by luciferase based transient-transfection assay
|
[PMID: 20855726] |
In Vitro
ACH-806 is an NS4A antagonist which can inhibit Hepatitis C Virus (HCV) replication with an EC50 of 14 nM. ACH-806 treatment results in significant reductions of both NS3 and NS4A in the transfected cells. This finding is reminiscent of ACH-806-treated replicon cells in which the amounts of NS3 and NS4A are also both decreased. The total amount of NS3 in the ACH-806-treated sample is reduced by ~6-fold (100/16) and causes a reduction of NS4A-bound NS3 ~29-fold (261/9). The levels of labeled NS3 and NS4A immunoprecipitated by anti-NS3 antibody are apparently reduced after the treatment of ACH-806. ACH-806 also induces significant decreases of NS3 and NS4A and promotes p14 formation in the parental replicon cells but not in the ACH-806-resistant replicon cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
Chemical Information
-
CAS. Nr. 870142-71-5
-
Molecular Weight 411.44
-
Formel C19H20F3N3O2S
-
SMILES
O=C(C1=CC=CN=C1)NC(NC2=CC=C(OCCCCC)C(C(F)(F)F)=C2)=S
-
Synonyms
GS9132
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
ACH-806 Related Classifications
HY-19512 Related Classifications
Powered by Bioz